{"id":2407,"date":"2023-01-27T00:00:00","date_gmt":"2023-01-27T05:00:00","guid":{"rendered":"https:\/\/mdbc2.wpenginepowered.com\/blog\/comorbidities-and-covid-19-what-your-metabolic-respiratory-and-cardiovascular-patients-need-to-know\/"},"modified":"2023-01-27T00:00:00","modified_gmt":"2023-01-27T05:00:00","slug":"comorbidities-and-covid-19-what-your-metabolic-respiratory-and-cardiovascular-patients-need-to-know","status":"publish","type":"blog","link":"https:\/\/www.mdbriefcase.com\/fr\/blog\/comorbidities-and-covid-19-what-your-metabolic-respiratory-and-cardiovascular-patients-need-to-know\/","title":{"rendered":"Comorbidities and COVID-19 \u2013 What Your Metabolic, Respiratory, and Cardiovascular Patients Need To Know"},"content":{"rendered":"

COVID-19 occurs due to the infection of a novel human coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus was first identified in China in 2019 and has since spread across human populations in more than 180 countries.<\/span><\/p>\n

SARS-CoV-2 can infect people of all age groups and genders. It can present with mild, moderate, or severe disease and usually involves respiratory symptoms. By <\/span>June 2022<\/span><\/a>, more than 530 million people worldwide had been diagnosed with COVID-19, with more than 6.3 million deaths.<\/span><\/p>\n

Comorbidity indicates when a person has more than one health condition simultaneously. Each condition is then considered a comorbidity (e.g., if a person with diabetes develops COVID-19).\u00a0<\/span><\/p>\n

What Is the Impact of COVID-19 on Patients With Respiratory, Cardiovascular, and Metabolic Conditions?\u00a0<\/b><\/h2>\n

COVID-19 disease progression is said to be much faster and more severe, even leading to death in some cases, among people with underlying health conditions.\u00a0<\/span><\/p>\n

Studies<\/span><\/a> show that people with obesity, complicated diabetes, and anxiety-related disorders have a higher risk (almost three times) of developing severe COVID-19 disease. Other diseases that have been associated with a higher COVID risk include cardiovascular (heart) disease, infections like viral hepatitis, metabolic conditions like diabetes and obesity, and respiratory diseases like asthma.<\/span><\/p>\n

Based on the prevalence of comorbid conditions globally, <\/span>one in five people<\/span><\/a> is believed to be at a higher risk of adverse COVID-19 outcomes. This risk also increases with age and the number of underlying health conditions. For instance, <\/span>older adults<\/span><\/a>, especially those above the age of 50 years, have a fourfold higher risk, whereas those above the age of 85 years have a tenfold higher risk.<\/span><\/p>\n

Meanwhile, the <\/span>risk of COVID-related death<\/span><\/a> also increases with the number of comorbidities. Compared to people with no underlying conditions, people with one comorbidity have a 1.5 times higher mortality risk, whereas people with more than 10 comorbidities have a 3.8 times higher mortality risk.<\/span><\/p>\n

How Can Healthcare Providers Protect Their Vulnerable Patients?\u00a0<\/b><\/h2>\n

Here are some recommendations from <\/span>Health Canada<\/span><\/a> for infection control during the COVID-19 pandemic:\u00a0<\/span><\/p>\n